Macular Degeneration Clinical Trials


Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

Condition:   Geographic Atrophy
Intervention:   Drug: RO7171009
Sponsor:   Genentech, Inc.
Recruiting

Learn More

First-In-Human Clinical Study of the C3 Complement Inhibitor AMY- 101 in Healthy Male Volunteers

Condition:   Complement Mediated Diseases
Intervention:   Drug: AMY-101
Sponsor:   Amyndas Pharmaceuticals S.A.
Recruiting

Learn More

AMD Ryan Initiative Study (ARIS)

Condition:   Age- Related Macular Degeneration
Intervention:  
Sponsor:   National Eye Institute (NEI)
Not yet recruiting

Learn More

RGX-314 Gene Therapy for Neovascular AMD Trial

Conditions:   Neovascular Age-related Macular Degeneration;   Wet Age-related Macular Degeneration
Intervention:   Biological: RGX-314
Sponsor:   Regenxbio Inc.
Recruiting

Learn More


Anti-VEGF Treatment for Prevention of PDR/DME

Conditions:   Diabetic Retinopathy;   Diabetic Macular Edema
Interventions:   Procedure: Prompt Sham;   Drug: Prompt aflibercept;   Procedure: Deferred laser;   Drug: Deferred aflibercept
Sponsors:   Jaeb Center for Health Research;   Regeneron Pharmaceuticals;   Juvenile Diabetes Research Foundation;   National Eye Institute (NEI);   National Institutes of Health (NIH)
Recruiting

Learn More


Phase I/IIa Study of SAR422459 in Patients With Stargardt's Macular Degeneration

Condition:   Stargardt Disease
Intervention:   Drug: SAR422459
Sponsor:   Sanofi
Recruiting

Learn More

Study of Dark Adaptation in Age-Related Macular Degeneration

Condition:   Age-Related Macular Degeneration
Intervention:  
Sponsor:   National Eye Institute (NEI)
Recruiting

Learn More

1-9 of 9
Results per page

Join the community!


You must be a member of healtheo360 in order to view this group

Register with Email Address

Already a member? Click here to login

healtheo360 believes strongly in user privacy.